Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Implementation license vs. portfolio license l2007s

It's all in the PR.

An Implementation License empowers manufacturers of microprocessors and/or other component parts to incorporate MMP technology (i.e. “Implementations”), while TPL retains the right to collect royalties from their customers that manufacture and sell finished, end-user products using the Implementations

They did, in fact, license the MMP Portfolio as manufacturers of microprocessors. Companies that use manufactured microprocessors in their end products eg auto manufacturers can/should also obtain a MMP Portfolio license.

Be well

Share
New Message
Please login to post a reply